John Ondrasik, PhD | Psychiatrist.com

Original Research

The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study

November 15, 2005

Mark H. Pollack, Peter P. Roy-Byrne, Michael Van Ameringen, et al